Does the gut microbiome really influence weight?

The question seems simple, but it has taken fifteen years for the scientific literature to build a clear answer. Today, that answer is clear, provided we accept one important nuance: the microbiome is one factor among many, not the only variable. Genetics, diet, sleep, physical activity, stress and medication all play a role. But the composition of the gut microbiota is now recognised as one of the best-documented modifiable factors.

This is one of the most counter-intuitive observations in recent research. Two people who consume exactly the same amount of food do not necessarily extract the same amount of energy from it. Certain microbial compositions, rich in bacteria that efficiently ferment fibre, release more usable calories from food that was not digested in the small intestine. This difference, measured in several clinical studies, can reach 150 to 200 kilocalories per day with the same food intake. Over a year, the cumulative difference becomes significant, and it is independent of a person's willpower or activity level.

In 2006, a study published in Nature marked a turning point: Ley and colleagues showed that people with obesity had a particular ratio between the two major bacterial groups in the colon, Firmicutes and Bacteroidetes, with a higher proportion of Firmicutes than in people with a stable weight². Since then, dozens of studies have confirmed that a less diverse gut microbiome, independently of this specific ratio, is more common among people who are overweight and is associated with chronic low-grade inflammation and reduced insulin sensitivity. Microbial diversity is now considered a broad marker of metabolic health.

For a long time, the question was debated: is an impoverished microbiome a cause of excess weight, or a consequence of it? Animal studies, in which the microbiome can be transplanted from one individual to another, have partly answered the question: transferring the gut microbiota of an obese mouse to a germ-free mouse of normal weight causes the second mouse to gain weight, even with an identical diet. In humans, the relationship is bidirectional: diet changes the microbiome, which in turn changes how calories are used and how fat is stored. Inserm describes the microbiome as a "metabolic organ in its own right", capable of influencing its host's energy balance¹.

Not all the energy contained in food is absorbed as it passes through the small intestine. Fibre, in particular, reaches the colon intact, where it is fermented by bacteria. This fermentation produces three essential molecules, short-chain fatty acids (SCFAs): butyrate, propionate and acetate. These SCFAs are not simply bacterial waste products: they are absorbed through the colonic wall and can account for up to 10% of daily energy intake in some people. A highly efficient microbiome extracts more energy; a less diverse microbiome allows more to pass through. This seemingly paradoxical mechanism helps explain why "eating less" does not always cause weight to change in the way we might expect.

The same SCFAs produced by the fermentation of soluble fibre act far beyond the colon: they stimulate the release of two gut hormones, GLP-1 and peptide YY (PYY), which signal fullness to the brain, reduce appetite and slow gastric emptying. An impoverished microbiome produces fewer SCFAs, and therefore fewer satiety signals. The result: you feel full for less time, snack more, and the cycle continues. Conversely, a microbiome rich in fibre-degrading bacteria prolongs satiety without conscious effort, one of the best-documented mechanisms through which the microbiome helps regulate weight.

When the microbiome is imbalanced, the intestinal barrier becomes more permeable and allows bacterial fragments called lipopolysaccharides (LPS) to enter the bloodstream. These molecules trigger low-grade systemic inflammation, too mild to be felt, but sufficient over time to disrupt insulin signalling. A landmark review of the metabolic literature established this link between LPS-related endotoxaemia, chronic inflammation and insulin resistance³. Insulin resistance is one of the pathways leading to excess weight and type 2 diabetes. Restoring the integrity of the intestinal barrier, through diet, fibre and certain probiotic strains, therefore becomes a metabolic strategy in its own right.

Among the thousands of bacterial species found in the gut, one has attracted particular attention from researchers: Akkermansia muciniphila. This bacterium lives in the mucus layer lining the intestinal wall and helps maintain its integrity. Its presence is correlated with better metabolic health, stable weight, improved insulin sensitivity and lower inflammation. In 2019, a clinical study published in Nature Medicine showed that supplementation with pasteurised Akkermansia muciniphila in overweight adults significantly improved several metabolic markers, insulin sensitivity, cholesterol levels and inflammation, without adverse effects⁴. This strain is now considered one of the so-called "next-generation" probiotics being studied for potential future clinical applications.

What follows is not a miracle list, it is what the scientific literature has documented most robustly to support a microbiome associated with healthy weight balance.

Prebiotics are a particular category of fibre, inulin, fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS), that selectively feed beneficial bacteria in the colon. They are found in artichokes, chicory, garlic, onions, leeks, slightly unripe bananas, Jerusalem artichokes and asparagus. Each day, an adult should aim for 25 to 30 grams of fibre in total, with a significant proportion coming from soluble fermentable fibre, the official ANSES recommendation for overall nutritional balance⁷. Average fibre intake in France remains around 17–20 grams, well below the target. Closing this gap is probably the number one dietary strategy for supporting a diverse microbiome and a stable weight.

Berries, green tea, raw cacao, extra virgin olive oil, aromatic herbs, coffee and spices are all rich sources of polyphenols. These plant compounds, long studied for their direct antioxidant effects, are now recognised for a more subtle role: they selectively modify the composition of the microbiome, promote the growth of strains associated with good metabolic health (including Akkermansia muciniphila), and reduce low-grade intestinal inflammation. A review published in PMC summarised the available data on this microbial modulation by polyphenols and highlights the potential of this class of compounds in preventive nutritional strategies⁸.

Traditional yoghurt, kefir, kombucha, raw sauerkraut, kimchi, miso, sourdough bread and probiotic shots all share the same fundamental mechanism, lactic fermentation by lactic acid bacteria and sometimes yeasts, which transforms sugars in food into lactic acid and enriches the product with live microorganisms. These foods directly provide beneficial strains, mainly Lactobacillus and Bifidobacterium, which several studies show contribute to improving microbial diversity, digestion and satiety regulation. The French Gut project led by INRAE is specifically exploring these links between fermented food heritage and microbial signatures among the French population⁵.

The opposite is equally well documented. Ultra-processed foods (industrial products classified as NOVA 4), excessive added sugars, regularly consumed non-caloric sweeteners, daily alcohol consumption and certain food emulsifiers reduce microbial diversity and promote a microbiome associated with inflammation and excess weight. This deterioration is gradual and often silent, but it helps explain why a diet low in processed foods often improves weight without any deliberate change in calorie intake.

This is the most frequently asked question, and the one where commercial promises most regularly exceed the scientific evidence. Here is what the clinical literature actually shows.

Several recent meta-analyses have synthesised randomised clinical trials evaluating the effect of certain probiotic strains on weight and body mass index (BMI). The results are modest but real: an average reduction in BMI of 0.2 to 0.6 kg/m² among overweight people who regularly take targeted probiotics, over a period of 8 to 24 weeks, using specific strains⁶. The best-documented strains to date are Lactobacillus gasseri (particularly SBT2055), Lactobacillus plantarum and Bifidobacterium lactis. The observed effect occurs mainly through improved satiety, reduced systemic inflammation and better blood glucose regulation, not through a direct effect on body fat.

To date, no probiotic strain has demonstrated a weight-loss effect in the absence of dietary changes. The most rigorous studies show significant results only when supplementation accompanies a balanced diet and regular physical activity. Claims such as "weight-loss probiotic" or "fat-burning strain" go far beyond the available evidence. The World Gastroenterology Organisation also points out that the choice of strain should be adapted to a specific indication, and that no single strain covers all the benefits attributed to the generic term "probiotic"¹⁰.

Probiotics are neither a treatment nor a shortcut. They are part of an overall approach, a diet rich in soluble fibre and polyphenols, a variety of fermented foods, sufficient sleep, daily physical activity and stress management. Within this framework, they provide a modest but measurable benefit, complementing more fundamental strategies. Viewed differently, they lead to disappointment. Viewed in their proper role, they form part of a sustainable strategy.

There is a lot of discussion about diet, but less about the two factors that underpin it: sleep and meal timing. Yet their impact on the microbiome, and therefore on weight, is far from marginal.

Recent research has shown that the composition and activity of the gut microbiome vary throughout the day, in synchronisation with the host's biological clock. This rhythmicity is disrupted by jet lag, night work, very late meals and chronic sleep deprivation. A review published in PMC documented the link between disruption of the microbiome's circadian rhythm and weight gain, insulin resistance and systemic inflammation⁹. Keeping relatively consistent meal times and allowing a nightly fasting window of at least 12 hours is a practical way to preserve this natural rhythm.

A short night's sleep alters appetite hormones within just a few hours: ghrelin (which stimulates hunger) increases, while leptin (which signals satiety) decreases. The result is a greater feeling of hunger the following day, an increased attraction to energy-dense foods, and a prefrontal cortex that is less effective at resisting cravings. Seven to nine hours of regular sleep is not a luxury: it is probably the most powerful hormonal lever for stabilising appetite and supporting a microbiome-focused dietary approach. No nutritional strategy can compensate for chronically insufficient sleep.

Minimiil is not a weight-loss product, and has never claimed to be one. It is a 60-millilitre fermented plant-based shot, organic almond milk fermented with four active probiotic strains (Lactobacillus plantarum, L. rhamnosus, Streptococcus thermophilus, L. delbrueckii), combined with 2.1 grams of prebiotic fibre (agave inulin), blackcurrant-blueberry and a little basil. Organic, Nutri-Score A, with no added sugar. It fits precisely into the approach described in this article: providing, as part of a simple daily ritual, elements that support a diverse microbiome, soluble fibre, live cultures and polyphenols from red berries.

No miracle weight-loss claims. A daily source of support, to be combined with a diet rich in whole plant foods, sufficient sleep and regular physical activity. The microbiome-metabolic health approach is a long-term process, not a shortcut.

References

¹ Inserm
² PubMed
³ PMC
⁴ PubMed
⁵ INRAE
⁶ PMC
⁷ ANSES
⁸ PMC
⁹ PMC
¹⁰ WGO